Clinical trial
Economic Impact of Metagenomic Next-generation Sequencing Versus Traditional Bacterial Culture Directed CNSIs Diagnosis and Therapy in Post-neurosurgical Patients Using a Decision Analysis Model
NCT05887037 is registered in ClinicalTrials.gov with Jian-Xin Zhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Economic Impact of Metagenomic Next-generation Sequencing Versus Traditional Bacterial Culture Directed CNSIs Diagnosis and Therapy in Post-neurosurgical Patients Using a Decision Analysis Model
- Lead sponsor
- Jian-Xin Zhou
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- July 1, 2025
- Enrollment
- 204 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.